1. Home
  2. BYFC vs XGN Comparison

BYFC vs XGN Comparison

Compare BYFC & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadway Financial Corporation

BYFC

Broadway Financial Corporation

N/A

Current Price

$7.60

Market Cap

71.7M

Sector

Finance

ML Signal

N/A

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$2.88

Market Cap

74.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BYFC
XGN
Founded
1946
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.7M
74.6M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
BYFC
XGN
Price
$7.60
$2.88
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$9.14
AVG Volume (30 Days)
1.6K
307.2K
Earning Date
07-31-2025
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$155,000.00
N/A
Revenue This Year
N/A
$12.51
Revenue Next Year
N/A
$13.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.51
$2.65
52 Week High
$8.85
$12.23

Technical Indicators

Market Signals
Indicator
BYFC
XGN
Relative Strength Index (RSI) 42.29 34.41
Support Level $7.19 N/A
Resistance Level $7.85 $3.89
Average True Range (ATR) 0.06 0.23
MACD -0.02 0.00
Stochastic Oscillator 21.43 19.35

Price Performance

Historical Comparison
BYFC
XGN

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Share on Social Networks: